Four characters, dot-com, and a designation that sounds like it came from a bench.
GL17 has the cadence of a real laboratory label — letter pair, sequential number, nothing wasted. In peptide and biotech circles that cadence carries authority automatically, because it is how compounds are actually referenced in submissions, batch records, and conference abstracts. On the .com extension, it becomes the kind of address a company builds a decade of identity on.
Owners who benefit most are those tired of explaining a spelled-out name over the phone: a synthesis firm, a clinical-stage developer, a research supply group consolidating several sub-brands. Short alphanumeric dot-coms are finite and quietly contested. This one is pronounceable, typo-resistant, and flexible enough to carry a pipeline rather than a single product.
Well suited to
Ideal owner A biotech or peptide manufacturer wanting a short, permanent corporate dot-com.
Acquire GL17.com outright, structure a strategic lease, or arrange lease-to-own — qualified inquiries only. Transactions are handled discreetly and can be escrow-secured.
